TY  - GEN 
AU  - Martín-Hernández, E.
AU  - Quijada-Fraile, P.
AU  - Correcher, P.
AU  - Meavilla, S.
AU  - Sánchez Pintos, Paula
AU  - de las Heras Montero, J.
AU  - Blasco-Alonso, J.
AU  - Dougherty, L.
AU  - Marquez, A.
AU  - Peña-Quintana, L.
AU  - Cañedo, E.
AU  - García-Jimenez, M.C.
AU  - Moreno Lozano, P.J.
AU  - Murray Hurtado, M.
AU  - Camprodon Gómez, M.
AU  - Barrio-Carreras, D.
AU  - de los Santos, M.
AU  - del Toro, M.
AU  - Couce Pico, María Luz
AU  - Vitoria Miñana, I.
AU  - Morales Conejo, M.
AU  - Bellusci, M.
PY  - 2022
SN  - 2077-0383
UR  - http://hdl.handle.net/20.500.11940/20669
AB  - Background and objectives: Glycerol phenylbutyrate (GPB) has demonstrated safety and efficacy in patients with urea cycle disorders (UCDs) by means of its clinical trial program, but there are limited data in clinical practice. In order to analyze the...
LA  - eng
TI  - Switching to Glycerol Phenylbutyrate in 48 Patients with Urea Cycle Disorders: Clinical Experience in Spain
DO  - 10.3390/jcm11175045
KW  - AS Santiago
KW  - CHUS
KW  - IDIS
VL  - 11
ER  -